loader2
Login OPEN ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

India's inclusion in JP Morgan EM Bond Index: What does it mean for India?

26 Sep 2023|
5 min read |
by ICICI Securities Team

After two years of monitoring, JP Morgan has made a significant decision to include India in its Government Bond Index-Emerging Markets, also known as GBI-EM index. In this article, we will look at how this move will help India, as it is expected to bring approximately $30 billion into the domestic debt market.

Inclusion Details

JP Morgan will start the inclusion process next year in June with a weight of 1%. The weightage will increase every month by 1%, and by April 2025, the overall weightage will go to 10%, with a monthly inflow of $3 billion to the domestic market. 

Earlier, such investments were not possible. However, the move has been supported by the government's introduction of the FAR program in the February 2020 budget and a leg up in market reforms for aiding foreign portfolios.

After the inclusion process is completed, the Indian market will become the second-largest emerging market country after China. Asia's exposure to the index will touch 50%. Some country's exposure will be reduced, with Thailand at 1.65%, Poland at 1.27%, Brazil at 1%, the Czech Republic at 1%, South Africa at 1.36%, Colombia at 0.78%, and Romania at 0.65%.

How will the inclusion benefit India?

Let us look at how the inclusion will benefit India. Below are areas of benefit for India:

Rupee to stabilize: As stated above, the inclusion will bring $30 billion to the Indian domestic bond market. To buy the bonds, the dollar has to be converted to a rupee, which will help to increase its value and eventually help stabilize the Indian rupee.

Lower cost of borrowing: The inflows will ensure that there is a reduction in borrowing costs for Indian corporates with the flow of foreign money. As per available data, the government mops 60% of the funds available in the debt markets domestically. It leaves very little for the corporates in the debt markets. The scarcity leads to higher costs of borrowing for Indian companies. Now that foreign investment is coming for government bonds, the domestically available capital for debt markets for corporates will increase.

Equity market to benefit: Foreign Institutional Investors (FII) closely track the dollar-rupee equation. If the rupee is expected to become stronger, their returns will be impacted. In such a case, they avoid investing in the Indian equity market. However, as mentioned above, the inclusion will stabilize the rupee, which will make Indian equity attractive to FIIs as it will sustain profit margins for them.

Also, with a lower cost of borrowing, the profits of Indian companies will increase because of higher margins. The better performance of Indian companies will attract more investors.

Downsides of inclusion in the index

As per market experts, the inclusion brings with it certain risks. Here are the key risks:

  • The inclusion can lead to volatility in global commodity prices, such as oil. 
  • There could be a deterioration in domestic fundamentals, i.e., high inflation or a slowdown in growth.

The final thought

With this inclusion, in the near term, it is expected that the 10-year benchmark government bond and rupee to outperform.  

Also, it opens the door for India's inclusion in other indices. For example, in coming years, India could become part of the Bloomberg Global Aggregate Index. It could attract another $10 to $15 billion, with India's weight ranging from 0.6% to 0.8%. 

Disclaimer: ICICI Securities Ltd.( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Centre, H. T. Parekh Marg, Churchgate, Mumbai - 400020, India, Tel No : 022 - 2288 2460, 022 - 2288 2470.  The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  Investments in securities market are subject to market risks, read all the related documents carefully before investing. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents are solely for informational and educational purpose.

Share
instagram facebook twitter linkedin mail whatsApp
Did you enjoy this article?

Recent Articles

View all

Repo Rate Hike Explained: Impact on Loans, Deposits, Bonds and Stock Market

13 Oct 2026

The Reserve Bank of India (RBI) held its 63rd Monetary Policy Committee (MPC) meeting from October 5 to 7, 2026. It raised the policy repo rate by 25 basis points. The stance was also changed from ‘neutral’ to ‘calibrated tightening’. India’s economy continued to show strong momentum, with real Gross Domestic Product (GDP) growing by 7.8% in Q1 FY2026-27. While inflation rose to 4.8% in August, the overall economic outlook remained positive. However, rise in crude oil prices amid renewed tensions in West Asia added to global uncertainties. This made it imperative for the RBI to strike a balance between the economic growth and price stability....

Jio Platforms IPO: RHP Highlights, Industry Analysis and Key Numbers

09 Oct 2026

Jio Platforms is the company behind Reliance Jio's mobile network, home broadband and a growing line-up of AI-powered products. The company filed its Draft Red Herring Prospectus (DRHP) with SEBI on June 19, 2026, and Red Herring Prospectus (RHP) on October 14, 2026. The Jio Platforms IPO opens on October 21, 2026 and closes on October 23, 2026. The RHP gives details about how the Jio Platforms IPO is structured, who currently owns the company, and where the raised money will be used. This article analyses RHP and says about how the issue is structured, how it is divided among investors, who is managing it, who owns the company today, the numbers behind the business and the market it operates in. It is for information only and not an investment advice....

Natco Pharma Ltd. Rights Issue: Price, Record Date, Entitlement Ratio And Key Details

09 Oct 2026

The Natco Pharma Ltd. rights issue is proposed at ₹750 per share, with eligible shareholders entitled to two rights equity shares for every 21 fully paid-up equity shares held on the record date. The issue is scheduled to open on October 12, 2026, and close on October 22, 2026. The pharmaceutical company plans to raise up to ₹1,279.35 crore through the issue, subject to full subscription and the finalisation of the basis of allotment....

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere